SCHEMBL2000447

SCHEMBL2000447

CS(=O)(=O)Oc1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
GAA P10253 2/20 0.50
PKM P14618 1/20 0.50
ENPP2 Q13822 1/20 0.50
ESR2 Q92731 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ESR1 P03372 1/20 0.46
ENPP3 O14638 1/20 0.44
ENPP1 P22413 1/20 0.44
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP7 P09237 1/20 0.43
MMP9 P14780 1/20 0.43
MMP14 P50281 1/20 0.43
LTA4H P09960 1/20 0.43
ELANE P08246 1/20 0.43
CA2 P00918 5/20 0.42
CA9 Q16790 3/20 0.42
CA12 O43570 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL27743268 0.98 ALDH1A1 (0.50) ALDH1A1GAAPKMENPP2ESR2
SCHEMBL4665449 0.94 ESR2 (0.54) ALDH1A1GAAPKMENPP2ESR2
SCHEMBL575589 0.87 CA2 (0.52) ALDH1A1GAAENPP3ENPP1MMP1
SCHEMBL15165583 0.82 ESR1 (0.43) ALDH1A1GAAPKMENPP2ESR2
SCHEMBL5184334 0.81 LMNA (0.69) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL18815812 0.80 MEN1 (0.50) ALDH1A1GAAPKMENPP2ESR2
SCHEMBL3838977 0.80 CA2 (0.58) ALDH1A1GAAMEN1KMT2AENPP3
SCHEMBL168170 0.78 CA2 (0.64) ALDH1A1GAAENPP3ENPP1MMP1
SCHEMBL6941035 0.78 CA1 (0.64) ALDH1A1GAAPKMMMP1MMP2
SCHEMBL232089 0.78 CISD1 (0.58) ALDH1A1GAAPKMENPP2ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4250245-A EMULSION LAYER CONTAINS A HYDROQUINONE ESTER OR SULFONATE EASTMAN KODAK COMPANY (US) 1981-02-10 US claimed
US-4201578-A HYDROQUINONE ESTERS EASTMAN KODAK COMPANY (US) 1980-05-06 US claimed
EP-4140981-B1 USE OF A METHANE-PRODUCTION INHIBITOR COMPOSITION AND METHOD FOR INHIBITING METHANE PRODUCTION KUMIAI CHEMICAL INDUSTRY CO (JP) 2025-02-12 EP disclosed
CN-115298287-B Methanogenesis inhibitor composition and method for inhibiting methanogenesis 组合化学工业株式会社 2024-05-14 CN disclosed
US-20240027902-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-01-25 US disclosed
US-20240027902-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-01-25 US disclosed
US-20230359119-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-09 US disclosed
US-11795145-B2 Methane-production inhibitor composition and method for inhibiting methane production KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2023-10-24 US disclosed
US-11795145-B2 Methane-production inhibitor composition and method for inhibiting methane production KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2023-10-24 US disclosed
US-20230305393-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-28 US disclosed
US-20230305394-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-28 US disclosed
US-5985897-A METHODS OF INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, AND CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS, INCLUDING HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER ELI LILLY AND COMPANY 1999-11-16 US disclosed
EP-0838462-A1 Benzothiophene compounds, intermediates, compositions, and methods ELI LILLY AND COMPANY (US) 1998-04-29 EP disclosed
CN-1145380-A Monozao compounds and dyeing or printing methods using the same SUMITOMO CHEMICAL CO (JP) 1997-03-19 CN disclosed
EP-0053010-B1 ACIDIC ADHESIVE COMPOSITIONS AND IMAGE RECORDING PRODUCTS CONTAINING SAME EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-01-09 EP disclosed
US-4357408-A NEUTRALIZATION; MASKING EASTMAN KODAK COMPANY (US) 1982-11-02 US disclosed
EP-0053010-A1 Acidic adhesive compositions and image recording products containing same EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1982-06-02 EP disclosed
US-4112083-A NEMATOCIDE, INSECTICIDE, MITICIDE, FUNGICIDE ROHM AND HAAS COMPANY (US) 1978-09-05 US disclosed
US-4053499-A PESTICIDES ROHM AND HAAS COMPANY (US) 1977-10-11 US disclosed
US-3975420-A PESTICIDE ROHM AND HAAS COMPANY (US) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795145-B2 Methane-production inhibitor composition and method for inhibiting methane production MSMO1, MRM1, MTR ALDH1A1 2630/4885GAA 3957/4885PKM 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.